Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities

NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities

Sep 09, 2020
|
staff reporter

NEW YORK — The New York Genome Center (NYGC) said on Tuesday that its Polyethnic-1000 research initiative has been awarded up to $2.1 million in grant funding over the next two years to support six projects using sequencing and other technologies to investigate the role of ethnicity in cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

Apr
27
Featured Webinar

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Apr
28
Featured Webinar

Spatial Multiomics: Analysis Strategies for Enriching Single-Cell Phenotyping Data: Integrative Analysis of Single-Cell Omics and Imaging Data

Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

What's Popular?

In Cancer

  1. Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

    Premium

  2. Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

  3. FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

    Premium

  4. Cancer Dx Firm C2i Genomics Raises $100M in Financing

  5. Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.